Why the study?
Does the racemic mixture of nebivolol (D-L-nebivolol) improve left ventricular systolic and diastolic function compared to its isolated enantiomers or atenolol in patients with ischemic heart disease?
Does the racemic mixture of nebivolol (D-L-nebivolol) improve left ventricular systolic and diastolic function compared to its isolated enantiomers or atenolol in patients with ischemic heart disease?
Answers are grounded in this paper and cite their sources.
The beneficial effects of nebivolol on left ventricular systolic and diastolic hemodynamics require the racemic mixture of both D- and L-enantiomers, which outperforms atenolol in preserving cardiac output and ejection fraction.
(D-L) Nebivolol is a new beta 1-selective adrenoceptor blocker which in normal individuals preserves rest and exercise hemodynamics. We assessed the effects of the enantiomers (L- and D-nebivolol) on left ventricular (LV) systolic and diastolic function and compared their effects with those of the racemic mixture. LV angiography (+Millar) was performed before and after intravenous (i.v.) infusion of either D- or L-nebivolol (1.25-2.5 mg, n = 22) in patients with ischemic heart disease and previous myocardial infarction. Neither L- nor D-nebivolol produced significant changes in heart rate (HR), peak (+) dP/dt, (dP/dt) DP40, cardiac index (CI) or ejection fraction (EF). Diastolic distensibility, evaluated from the shift of the pressure-volume data at the time of mitral valve opening, did not improve after D- or L-enantiomers administration. In contrast, both D-L-nebivolol 2.5 mg (n = 9) and atenolol 15 mg (n = 9) significantly reduced HR and peak (+) dP/dt, but in comparison to atenolol D-L nebivolol improved EF (+4% after D-L nebivolol vs. -4% after atenolol; p < 0.05 D-L nebivolol vs. atenolol) and maintained cardiac output CO, (+2% vs. -21%; p < 0.05 between groups). Moreover, unlike any of the other drugs in the study, the racemate shifted the diastolic pressure-volume data downward, suggesting improved LV distensibility. The beneficial effects of nebivolol on LV systolic and diastolic function appears to require the presence of both D- and L-enantiomers.
No takes yet. Share an insight, caveat, or question.
Stoleru et al. (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: